The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells

Journal of Immunology

Volumn 166, Issue 5, 2001, Pages 3231-3239

  Navratil, J S ^a   Watkins, S C ^a   Wisnieski, J J ^a   Ahearn, J M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C4; COMPLEMENT RECEPTOR;

ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; CELL SURFACE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; KERATINOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0035284867     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.5.3231     Document Type: Article

References (69)

1. Complement deficiency and immune complex disease
2. Complement deficiency and autoimmunity
3. C1q deficiencies and C1q in autoimmunity
4. Systemic lupus erythematosus and complement deficiency: Clues to a novel role for the classical complement pathway in the maintenance of immune tolerance
5. Toward an understanding of the molecular mechanisms of physiological cell death
6. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes
7. Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes
8. Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleo-protein is a characteristic biochemical feature of apoptotic cell death
9. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis
10. Apopain/CPP32 cleaves proteins that are essential for cellular repair: A fundamental principle of apoptotic death
11. Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis
12. The 72-kDa component of signal recognition particle is cleaved during apoptosis
13. Granzyme B directly and efficiently cleaves several downstream caspase substrates: Implications for CTL-induced apoptosis
14. Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus
15. Novel packages of viral and self-antigens are generated during apoptosis
16. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
17. 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
18. Delayed clearance of apoptotic lymphoma cells allows cross-presentation of intracellular antigens by mature dendritic cells
19. Cellular vaccines
20. Antigen-presenting cells that phagocytose apoptotic tumor-derived cells are potent tumor vaccines
21. Systemic exposure to irradiated apoptotic cells induces autoantibody production
22. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: Complement deficiency and systemic lupus erythematosus revisited
23. Activation of C1 by monoclonal antibodies directed against C1q
24. IgG autoantibody to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus, and 6 other musculoskeletal or rheumatic diseases
25. Isolation of the globular region of the subcomponent 1 of the C1 component of complement
26. Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis)
27. The classical complement pathway: Activation and regulation of the first complement component
28. Homeostasis and self-tolerance in the immune system: Turning lymphocytes off
29. Molecules involved in cell death and peripheral tolerance
30. Monocytes stimulate expression of the Bcl-2 family member, Al, in endothelial cells and confer protection against apoptosis
31. Overexpression of Al, an NF-κB-inducible anti-apoptotic Bcl gene, inhibits endothelial cell activation
32. Sickle cell anemia as a possible state of enhanced anti-apoptotic tone: Survival effect of vascular endothelial growth factor on circulating and unanchored endothelial cells
33. Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q
34. Intracellular localization of the human receptor for the globular domains of C1q
35. The multiligand-binding protein gC1qR, putative C1q receptor, is a mitochondrial protein
36. Subcellular targeting of multiligand-binding protein gC1qR
37. Structure and function of gC1q-R: A multiligand binding cellular protein
38. Murine mast cells express two types of C1q receptors that are involved in the induction of chemotaxis and chemokinesis
39. Localisation of the C1q binding site within C1q receptor/calreticulin
40. H2-like immunoglobulin γ motifs present in the autoantigen calreticulin and interferes with complement activation
41. Clinical relevance of calreticulin in systemic lupus erythematosus
42. The systemic lupus erythematosus (SLE) disease autoantigen-calreticulin can inhibit C1q association with immune complexes
43. The unveiling of calreticulin: A clinically relevant tour of modern cell biology
44. Impact of ultraviolet radiation on the cellular expression of Ro/SS-A-autoantigenic polypeptides
45. Regulation of expression of the polypeptide constituents of the Ro autoantigen complex in transformed human epidermal keratinocytes
46. Effect of ultraviolet irradiation on selected host cell proteins including Ro/SS-A and Epstein-Barr virus in cultured lymphoblastoid cell lines
47. The structure and function of the first component of complement: Genetic engineering approach
48. Subunit composition and structure of subcomponent C1q of the first component of human complement
49. cDNA cloning and primary structure analysis of C1qRP, the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro
50. p, the C1q receptor that enhances phagocytosis, is detected specifically in human cells of myeloid lineage, endothelial cells, and platelets
51. Complement receptor type I (CR1, CD35) is a receptor for C1q
52. C1q receptors: Regulating specific function of phagocytic cells
53. C1q-binding proteins and C1q receptors
54. Membrane receptors for soluble defense collagens
55. Cell-surface protein identified on phagocytic cells modulates the C1q-mediated enhancement of phagocytosis
56. Identification of a restriction fragment polymorphism by a CR1 cDNA that correlated with the number of CR1 on erythrocytes
57. Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: Analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene
58. Family studies of erythrocyte complement receptor type 1 levels: Reduced levels in patients with SLE are acquired, not inherited
59. Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus
60. Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus
61. The rate of loss of CR1 from aging erythrocytes in vivo in normal subjects and SLE patients: No correlation with structural or numerical polymorphisms
62. Urticarial vasculitis
63. Autoantibodies to the collagenous region of C1q occur in three strains of lupus-prone mice
64. Hypocomplementemic urticarial vasculitis syndrome: Clinical and serologic findings in 18 patients
65. Low-molecular weight C1q-binding IgG in patients with SLE consists of auto-antibodies to the collagen-like region of C1q
66. C1q as antigen in humoral autoimmune responses
67. Autoantibodies in systemic lupus erythematosus and urticarial vasculitis
68. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
69. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo